undamentalytics Newsletter
Sign in

Sunshine Biopharma Inc. balance sheet

At the end of fiscal 2025, Sunshine Biopharma Inc. had total assets of $30.1m, total liabilities of $7.0m and shareholders' equity of $23.0m. It held $9.1m in cash against $0 of debt: net cash of $9.1m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents00012221610914
Receivables0000023434
Inventory—000036111312
Total current assets010122725262731
Goodwill011—0000——
Total assets010122927313034
Accounts payable0000033665
Total current liabilities1111076666
Long-term debt000120————
Total debt1112200000
Total liabilities1112286776
Shareholders' equity−1−0−1−102221242328
Net debt (negative = net cash)0111−0−22−16−10−9−14
Shares outstanding46m———3m———4m2m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: BGM vs SBFMIMCC vs SBFMSBFM vs SCLXCPIX vs SBFM

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Sunshine Biopharma Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Sunshine Biopharma Inc.